SPOTLIGHT: Calif. stem cell agency struggles to keep talent

Assembling and keeping talent at California's stem cell agency continues to be a sore point. Interim scientific director Arlene Chiu has announced her resignation. The group is now the single largest supporter of embryonic stem cell research, but so far it has not been able to line up a group of top administrators. Report

Suggested Articles

Genor Biopharma banked $160 million from the likes of Hillhouse and Temasek Holdings to advance its clinical-stage autoimmune and cancer programs.

Going from being the CSO of Bristol Myers Squibb to running one of the biggest cancer research organizations in the world is a major career shift.

Hahn made the commitment in a speech that called on the FDA to learn from the crisis to enact lasting policies that accelerate drug development.